Gland Pharma Q2 result: Net profit fell 20% to Rs 194 cr on higher expenses
Indian generic injectables maker Gland Pharma posted a weaker-than-expected second-quarter profit on Monday, as higher employee expenses eclipsed strong
Continue readingThe Number One Finance & Business Blog!
Indian generic injectables maker Gland Pharma posted a weaker-than-expected second-quarter profit on Monday, as higher employee expenses eclipsed strong
Continue readingThe company also reported a year-on-year improvement in demand for their generic API business | Photo: Twitter Pharmaceutical company Piramal
Continue readingPharmaceutical manufacturer Sun Pharma on Thursday announced that one of its wholly-owned subsidiaries has entered into a licenseing agreement
Continue reading